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ABSTRACT 
Objectives: To assess the cytotoxicity of Arbutus pavarii Pamp. (fam. Ericaceae), a Libyan 
medicinal plant, against human cancer cell lines and to carry out bioassay-guided isolation 
and identification of compounds. 
Materials and Methods: Shed-dried and ground leaves of A. pavarii were Soxhlet-extracted, 
successively, with n-hexane, dichloromethane (DCM) and methanol (MeOH), and assessed for 
cytotoxicity against several human cancer cell lines using the MTT assay. The cytotoxicity of 
the DCM extract against the normal human prostate cell line PNT2 was also assessed to 
determine the selectivity index (SI). The DCM extract was subjected to vacuum liquid 
chromatography (VLC) to produce eight fractions, which were then tested against the 
prostate cancer cell line PC3, as the DCM extract was considerably cytotoxic to this cell line. 
A reversed-phase preparative HPLC analysis of the active VLC fraction was carried out to purify 
the major compounds present in the active fraction, and the structures of the compounds 
were elucidated by spectroscopic means. 
Results: The DCM extract displayed most prominent cytotoxicity against the PC3 cell line with 
an IC50 value of 26 g/mL. However, this extract was much less cytotoxic to the normal human 
prostate cell line PNT2 (IC50 = 90 g/mL) with a selectivity index of 3.5. VLC analysis produced 
eight fractions, and among them, fraction VLC-5 was most active against the PC3 cell line. 
Prep-HPLC-based purification of VLC-5 afforded the isolation of arbutin (1) and betulinic acid 
methyl ester (2), the structures of which were elucidated by spectroscopic means. 
Conclusion: The DCM extract of the leaves of A. pavarii exhibited significant cytotoxicity to 
PC3 cells, but much less cytotoxicity against normal human prostate cell line. The isolated 
compounds from the active fraction, arbutin (1) and betulinic acid methyl ester (2), which 
were previously shown to possess cytotoxic properties, could be responsible for the 
cytotoxicity of the DCM extract. 
Key words: Arbutus pavarii, Ericaceae, betulinic acid methyl ester, arbutin, prostate cancer, 
PC3, anticancer, Libya 
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INTRODUCTION 
Arbutus pavarii Pamp., commonly known as “Shmeri”, “Shmar” and “Libyan Strawberry”, is 
an endemic Libyan medicinal plant of the family Ericaceae.1,2 This evergreen shrub grows 
almost exclusively in the Al-Jabel Al-Akhdar mountainous region in Libya. It is a forage species 
of plant for honeybees to produce a specific type of honey, and has long been a component 
of Libyan traditional medicinal preparations for the treatment of both gastritis and kidney 
diseases.3 The berries of this plant are rich in minerals, nutrients, carbohydrates and ascorbic 
acid, and the aerial parts have their application in the tanning process.4 Previous 
phytochemical investigations performed on this species revealed the presence of simple 
phenolic compounds like arbutin (1) and gallic acid, and flavonoids and tannins, such as, 
apigenin, epicatechin, hesperidin, kaempferol, naringin, quercetin and rutin, as well as some 
triterpenes and sterols.1,3-6  Rutin and arbutin appear to be the most abundant compounds 
within the aerial parts of this plant, and arbutin (1) is considered as a chemotaxonomic marker 
for the genus Arbutus L.3-6 Only a few published reports on the bioactivities of this species 
described preliminary antioxidant, antimicrobial and cytotoxic activities of the crude extracts 
of this species. However, there is hardly any report on bioassay-guided isolation of any active 
compounds, and subsequent assessment of bioactivity of those compounds.1,3,4,7,8 We now 
report, for the very first time, on the assessment of cytotoxicity of the dichloromethane 
(DCM) extract against several human cancer cell lines, and a bioassay-guided isolation and 
spectroscopic identification of the major compounds, arbutin (1) and betulinic acid methyl 
ester (2), from the DCM extract of the leaves of A. pavarii. 
MATERIALS AND METHODS 
General experimental procedure 
1D and 2D NMR spectroscopic analyses were carried out on a Bruker 600 MHz AMX 
Ultrashield NMR spectrometer using the deuterium locking. Chemical shifts are in  ppm and 
coupling constants J in Hz.  Vacuum liquid chromatography (VLC) was performed on silica gel 
60H (Sigma-Aldrich, UK) column under vacuum. Solvents for extraction and chromatographic 
work were of analytical grade, obtained from Fisher Scientific, UK, and used without further 
purification. 
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Plant materials 
The leaves of Arbutus pavarii Pamp. (Ericaceae) (Figure 1) were collected from the Al-Jabal Al-
Akhdar region in Libya (latitude and longitude: 32° 35' 51'' North and 21° 28' 22'' East) in 2016, 
and a voucher specimen for this collection (D6854201) has been retained at the Herbarium 
of the Faculty of Science, Tripoli University, Libya. Shed-dried leaves were ground to a fine 
powder using a coffee grinder. 
 
Figure 1. Arbutus pavarii shrub 
Extraction 
A portion (150 g) of the ground leaves was Soxhlet-extracted, sequentially, with n-hexane, 
dichloromethane (DCM) and methanol (MeOH), 900 mL each and 10 cycles each solvent. All 
extracts were filtered using Whatman filter paper, evaporated to dryness using a rotary 
evaporator (Cole-Parmer, UK) and stored at 4oC. 
Vacuum liquid chromatography (VLC) 
VLC was carried out following the method described by Sarker and Nahar.9 The DCM extract 
(2.4 g) was subjected to VLC fractionation on a silica 60H column under vacuum using a step 
gradient comprising n-hexane, ethyl acetate (EtOAc) and MeOH of different proportions and 
in the order of increasing polarity, e.g., 100% n-hexane, 10, 30, 50, 80% EtOAc in n-hexane, 
100% EtOAc and 50% MeOH in EtOAc. 
Isolation of compounds by preparative high performance liquid chromatography (prep-HPLC) 
Preparative HPLC separation was performed on an Agilent 1200 preparative HPLC comprising 
a binary gradient pump, photodiode array detector and a computer with control and data 
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analysis software. In the preparative isolation of compounds, an ACE prep-column [150 × 21.2 
mm, 5 m, Hichrom Ltd, UK; MeOH-water linear gradient: 50-100% acetonitrile in water (both 
containing 0.1% 0.1% trifluoro acetic acid, TFA) in 30 min, then 100% acetonitrile for 10 min, 
flow rate: 10 mL/min, monitored simultaneously at 215, 254, 280 and 320 nm] was used with 
a volume of injection of 200 μL.  
Identification of compounds 
The identity of the isolated compounds (1) and (2) (Figure 2) was confirmed by spectroscopic 

















Figure 2: Structures of arbutin (1) and betulinic acid methyl ester (2) 
Cytotoxicity assay (MTT assay) 
Human cancer cell lines A549 (human lung carcinoma), EJ138 (human bladder carcinoma), 
HepG2 (human liver hepatocellular carcinoma), MCF7 (human breast adenocarcinoma) and 
PC3 (human prostate cancer) were used in this study. Additionally, the normal human 
prostate cell line PNT2 was used. These cell lines were obtained from the European Collection 
of Authenticated Cell Cultures. All the cancer cell lines were adherent epithelial cells derived 
from human carcinoma or adenocarcinoma. Cytotoxicity of the extracts of A. pavarii at 
different concentrations (0.0, 0.005, 0.01, 0.05, 0.1 and 0.5 mg/mL), after treatment for 24 h, 
was assessed against these cell lines using the MTT assay.10,11 The VLC fractions were assessed 
for cytotoxicity using the same assay but at different concentrations: 0.0, 0.0004, 0.002, 0.01, 
0.05 and 0.25 mg/mL. The IC50 values of these extracts against the tested cell lines (where 
appropriate), and that of the VLC fractions against the PC3 cell line were calculated applying 
the method described by Patel et al.12 Any IC50 value of greater than 100 g/mL was 
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considered non-cytotoxic. The cytotoxicity of the n-hexane extract could not be assessed 
because of its insolubility in DMSO. 
RESULTS 
The Soxhlet extraction of the shed-dried ground leaves of A. pavarii gave three different 
extracts, i.e., n-hexane, DCM ad MeOH, with 4.4, 1.8 and 36.0% yields, respectively. Because 
of insolubility issues, n-hexane extract was not subjected to cytotoxicity assay (MTT assay), 
but the other two extracts were assessed for their cytotoxicity against five different human 
cancer cell lines, and the DCM extract was found to be the most cytotoxic extract (Table 1). 
Additionally, the DCM extract was tested for cytotoxicity against the normal human prostate 
cell line PNT2 (Table 1), and the selectivity index (SI), which is the ratio between the IC50 values 
against the normal cells and the cancerous cells, was calculated.  
Table 1. Cytotoxicity of DCM extract of A. pavarii against five human cancer cell line and 
normal human prostate cell line PNT2 
Cancer cell lines Inhibitory concentration 50% (IC50) in 
g/mL 
A549 (human lung carcinoma) >100 
EJ138 (human bladder carcinoma)  90 
HepG2 (human liver hepatocellular carcinoma)  >100 
MCF7 (human breast adenocarcinoma)  >100 
PC3 (human prostate cancer) 26 
PNT2 (normal human prostate cells) 90 
As the DCM extract was significantly cytotoxic, and it showed the most prominent activity 
against the PC3 cell line, it was subjected to VLC fractionation resulting in eight different 
fractions (VLC-1 to VLC-8), which were then assessed for cytotoxicity against the PC3 cell line 
(Table 2)  
The most active fraction VLC-5 was subjected to reversed-phase preparative HPLC on a C18 
preparative column using a linear gradient elution with a mobile phase comprising 
acetonitrile and water (both containing 0.1% TFA). Preparative HPLC analysis of a portion of 
the fraction VLC-5 resulted in the isolation of two major compounds 1 and 2 (Table 3), which 
were identified as arbutin (1) and betulinic acid methyl ester (2) by spectroscopic analyses, 
7 | P a g e  
 
especially, MS, and 1D and 2D NMR, as well as by comparison with published data for these 
compounds.13-16  
Table 2. VLC fractions of the DCM extract of A. pavarii and their cytotoxicity against the PC3 
cell line 
VLC fractions Mobile phase composition Weight (mg) IC50 value in g/mL 
VLC-1 100% n-Hexane 150 >100 
VLC-2 10% EtOAc in n-hexane 65.2 >100 
VLC-3 30% EtOAc in n-hexane 41.7 >100 
VLC-4 50% EtOAc in n-hexane 165.7 40.0 
VLC-5 50% EtOAc in n-hexane 477.0 30.0 
VLC-6 80% EtOAc in n-hexane 117.0 98.0 
VLC-7 100% EtOAc 130.8 >100 
VLC-8 50% MeOH in EtOAc 97.1 >100 
Table 3. Isolation and identification of arbutin (1) and betulinic acid methyl ester (2) from the 
fraction VLC-5 of the DCM extract of A. pavarii (retention time and weight)  
Compounds Retention time (tR) in min* Weight in mg 
Arbutin (1) 17.2 2.6 
Betulinic acid methyl ester (2) 32.1 2.2 
*A gradient elution with 50-100% acetonitrile in water (both containing 0.1% 0.1% TFA) in 30 min, then 100% acetonitrile for 
10 min, flow rate: 10 mL/min. 
Arbutin (1): White powder; UV (MeOH) max: 212 and 282 nm; ESMS m/z: 273 [M+H]+; 1H NMR 
(600 MHz, in CD3OD):  6.77 d (J = 8.9 Hz, H-2 and H-6), 6.97 d (J = 8.9 Hz, H-3 and H-5), 4.81 
d (J = 7.6, H-1’), 3.50-3.91 (overlapped peaks, H-2’, H-3’, H-4’, H-5’ and H2-6’); 13C NMR (150 
MHz, in CD3OD):  151.8 (C-1 and C-4), 118.8 (C-2 and C-6), 116.3 (C-3 and C-5), 103.2 (C-1’), 
77.5 (C-3’), 77.0 (C-5’), 75.1 (C-2’), 71.5 (C-4’) and 62.7 (C-6’).13-15  
Betulinic acid methyl ester (2): White amorphous powder; UV (MeOH) max: 208 nm; ESMS 
m/z: 493 [M+Na]+; 1H NMR (600 MHz, in CD3OD): 4.77 bs and 4.64 bs (H2-29), 3.52 s (-
OCOMe) 3.22 dd ( J = 4.6 and 11.4 Hz, H-3), 3.10 m (H-19), 1.51 t (J = 3.6, H2-1), 1.80 m (H2-2), 
1.70 s (H3-30), 0.98 s (H3-27), 0.94 s (H3-26), 0.87 s (H3-25), 0.86 (H3-24) and 0.84 (H3-23); 13C 
NMR (150 MHz, in CD3OD):  178.8 (C-28), 151.0 (C-20), 110.0 (C-29), 78.4 (C-3), 56.6 (C-17), 
55.7 (C-5), 51.0 (C-9), 50.0 (-OCOMe), 49.0 (C-19), 47.4 (C-18), 42.8 (C-14), 41.0 (C-8), 39.5 (C-
4), 39.2 (C-1), 38.6 (C-13), 37.5 (C-22), 37.2 (C-10), 34.8 (C-7), 32.2 (C-16), 31.0 (C-21), 30.0 (C-
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15), 28.6 (C-23), 28.1 (C-2), 25.9 (C-12), 21.0 (C-11), 19.5 (C-30), 19.2 (C-20), 18.9 (C-6), 16.9 
(C-26), 16.3 (C-24), 16.2 (C-25) and 15.0 (C-27).16,17  
DISCUSSION 
The highest extraction yield was obtained by MeOH (36.0 %), which could be due to the 
presence of large amounts of polar phenolic and polyphenolic compounds (e.g., tannins) and 
their glycosides in the leaves. On the other hand, DCM produced the least extraction yield 
(1.8%), which is not surprising, as most non-polar compounds are generally extracted by n-
hexane and the polar compounds by MeOH, leaving DCM to extract only some compounds of 
medium polarity, and a few left over or trailing nonpolar compounds from the n-hexane 
extract and a small proportion of polar compounds that are fully extracted in the MeOH 
extract. 
In the MTT assay, the DCM extract showed significant cytotoxicity against the prostate cancer 
cell line PC3 (IC50 = 26 g/mL), and a moderate level of activity against the bladder cancer cell 
line EJ138 (IC50 = 90 g/mL) (Table 1). However, this extract did not show any cytotoxicity 
against three other cancer cell lines: HepG2, A459 and MCF7. Moreover, the cytotoxicity of 
the DCM extract against normal human prostate cell line PNT2 (IC50 = 90 g/mL) (Table 1) was 
much less than its activity against the prostate cancer cell line PC3. The selectivity index (SI) 
of the DCM extract was determined as 90/26 = 3.5, indicating its selective cytotoxicity toward 
cancer cells as opposed to normal cells. The MTT result also demonstrated that the 
cytotoxicity of the DCM extract was selective to certain cancer cells and was not cytotoxic to 
each cell line tested. 
As the DCM extract was most active against the PC3 cell line, this cell line was chosen for 
further bioassay-guided isolation processes, which started with the VLC fractionation of the 
DCM extract resulting in eight different fractions of different weights (Table 2). Fraction 
eluted with 50% EtOAc in n-hexane (VLC-5) was the highest yielding fraction (477 mg), 
followed by VLC-4 (165.7 mg), VLC-1 (150.0 mg) and so on (Table 2). The overall recovery of 
materials from the VLC process was 51.8%, which is quite usual in such operations.9 All eight 
fractions were subjected to the MTT assay using the PC3 cell line, and VLC-5 produced the 
most prominent cytotoxic effect against this cell line (IC = 30 g/mL) (Table 2), Therefore, 
this fraction was chosen for preparative HPLC analysis aiming at isolating major compounds 
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from this fraction. Fractions VLC-1, VLC-2, VLC-3, VLC-7 and VLC-8 were inactive against this 
cell line, while fractions VLC-4 and VLC-6, in addition to VLC-5, showed cytotoxicity with IC50 
values of 40 and 98 g/mL. As VLC-5 was the most active fraction, it was subjected to 
preparative HPLC analysis resulting in the purification of two compounds which were 
identified as arbutin (1)13-15 and betulinic acid methyl ester (2) by spectroscopic means. 
Compound 1 was eluted first (tR = 17.2 min) in the preparative HPLC run and obtained as a 
white powder. While the UV absorption maxima of this compound were 212 and 282 nm, the 
ESIMS analysis revealed the pseudomolecular ion [M+H]+ at m/z suggesting the molecular 
formula C12H16O7. Analyses of the 1H NMR and the 13C NMR spectra of compound 1 revealed 
signals assignable to the protons/carbons of a para-di-substituted aromatic ring at δH 6.97 (d, 
J = 8.9 Hz, 2H) and δC 116.3, and δH 6.77 (d, J = 8.9 Hz, 2H) and δC 118.8 and all required signals 
for a -D-glucopyranoside unit (data shown in the Results section). While a 1H-1H COSY 
spectrum showed all 1H-1H scaler couplings, a 1H-13C HMBC displayed all major 1H-13C long-
range correlations and helped identification of this compound as arbutin (1) (Figure 2). The 
most noteworthy HMBC correlation was the 3J correlation from the glucose anomeric proton 
(H 4.81) to the C-1 (C 103.2) of the aromatic ring. All data were comparable to the published 
data for arbutin (1).13-15 
Compound 2 was eluted beyond the gradient run duration and during the cleaning phase (tR 
= 32.1 min) in the preparative HPLC run, and obtained as a white amorphous powder, having 
a very low UV absorbance maximum at 208 nm. The ESIMS exhibited the sodiated molecular 
ion peak at m/z at 493 [M+Na]+ corresponding to the molecular formula C31H50O3. The 1H and 
13C NMR spectra showed characteristic signals for a betulinic acid skeleton with an additional 
methyl ester functionality16,17, including the signals for six methyl groups (H 1.70, 0.98, 0.94, 
0.87, 0.86 and 0.84; C 28.6, 19.5, 16.9, 16.3, 16.2 and 15.0), a hydroxyl group (H 3.22; C 
78.4), an olefinic methylene functionality (H 4.77 bs and 4.64; C 151.0) and a methyl ester 
group (H 3.52; C 178.8 and 50.0). Thus, the compound was identified as betulinic acid methyl 
ester (2), and all data were comparable to the literature data for this compound.16,17 
This is the first report on the assessment of cytotoxicity of any DCM extract of the leaves of 
A. pavarii against various human cancer cell lines, as well as the bioassay-guided isolation of 
main compounds (1 and 2) from the bioactive fraction. While the distribution of arbutin is 
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quite widespread within the genus Arbutus,18 this is the first report on the isolation of 
triterpene acid ester from A. pavarii. However, related pentacyclic triterpenes were 
previously isolated from the fruits of another species of this genus, A. unedo, for example, α- 
and β-amyrin, betulinic acid, lupeol olean-12-en-3,23-diol.19 Similarly, the cytotoxic 
properties of the MeOH extract of the aerial parts of A. pavarii were previously demonstrated 
against both HepG2 hepatic carcinoma and T47D breast cancer cell lines, and the IC50 values 
were determined as 19.7 and 19.0 g/mL, respectively.3 The cytotoxicity of the MeOH extract 
of the aerial parts of this plant was also shown against lung (A549) and breast (MCF7) cancer 
cell lines with IC50 values of below 30 g/mL.4 Notably, this is the first report on the 
assessment of cytotoxicity of any DCM extract of A. pavarii against the bladder (EJ138) and 
prostate cancer (PC3) cell lines. 
Arbutin (1) and its derivatives are known to possess cytotoxic as well as potential anticancer 
properties. Several arbutin derivatives with an acylated glucosyl unit were isolated from the 
leaves of Heliciopsis lobata and shown to possess cytotoxic property against the gastric cancer 
MGC803 cells and to inhibit MGC803 cell invasion.20 In a recent study looking into the possible 
mechanism of action of arbutin (1), it was observed that this compound could display 
anticancer activity against rat C6 glioma cells by prompting apoptosis as well as by inhibiting 
inflammatory marker and phosphoinositide 3-kinase (PI3K)/mammalian target of rapamycin 
(mTOR) signaling molecules.21 Moreover, arbutin (1) could generate excessive reactive 
oxygen species and disrupt the mitochondrial membrane resulting in induction of apoptosis 
in cells. Arbutin (1) and a few other phenolic compounds were assessed for their cytotoxic 
property against two human breast cancer cell lines, adriamycin-resistant MCF-7/Adr and 
wild-type MCF-7/wt,22 and arbutin (1) was found active only against the MCF-7/Adr cell line 
with an IC50 value of 5.58 mM. Hydroquinone, the aglycone of arbutin (1), showed 
antiproliferative activity against C6 and HeLa (human cervix carcinoma) cells, while arbutin 
(1) did not show antiproliferative activity in all tested doses.23 It can be noted here that C6 
cells are spindle-like cells that can stimulate human glioblastoma when they are injected in 
the brain of neonatal rats, and this cell line is considered as the gold standard in glioma 
research. 
Betulinic acid and its derivatives, e.g., betulinic acid methyl ester (2), are known to possess 
various bioactivities, including potential anticancer properties.23 In a study conducted by 
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Quang et al.24, betulinic acid methyl ester (2) as well as betulinic acid were tested for 
cytotoxicity against HeLa, HepG2, SK-LU-1 (human lung carcinoma), AGS (human stomach 
gastric adenocarcinoma) and SK-MEL-2 (human melanoma) cell lines, and it was found that 
both compounds could exert non-selective and a moderate level of cytotoxicity against all five 
cell lines.  Betulinic acid methyl ester (2) was particularly active against the SK-LU-1 cell line 
with an IC50 value of 60.84 g/mL, and the IC50 values against other cell lines were in between 
66.17 and 80.17 g/mL.  
CONCLUSIONS 
Bioassay-guided approach afforded isolation of arbutin (1) and betulinic acid methyl ester (2) 
as the main compounds present in the cytotoxic fraction of the DCM extract of the leaves of 
A. pavarii. The DCM extract showed remarkable cytotoxicity against the prostate cancer cell 
line PC3, but much less toxicity against normal human prostate cell line PNT2, meaning 
cytotoxicity being more selective to cancer cells over normal cells. This is the first report on 
the isolation of betulinic acid methyl ester (2) from the leaves of A. pavarii. As both 1 and 2 
were demonstrated previously to possess cytotoxic/antiproliferative properties against 
various human cell lines, and as they are present in the cytotoxic fraction of the DCM extract, 
it is reasonable to assume that the significant cytotoxicity of the DCM extract observed in the 
current study could be, at least partly, due to the presence of these two cytotoxic compounds.  
Further study involving these compounds and their structural analogues for their cytotoxic 
potential against human prostate cancer cell lines as well as mechanistic studies, e.g., 
apoptosis, necrosis and so on, could provide an insight into their structure-activity-
relationships and possible mechanisms of action. 
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